“…As the mitochondrial pyruvate carrier is central for cellular homeostasis, the identification of the MPC proteins intensified efforts to understand their role in cancer (Schell et al , , ; Yang et al , ; Zhong et al , ; Li et al , , ; Corbet et al , ; Ohashi et al , ; Bader et al , ), diabetes (Colca et al , ; Divakaruni et al , ; Vigueira et al , ; Gray et al , ; McCommis et al , , ; Vadvalkar et al , ) and neurodegeneration (Ghosh et al , ; Divakaruni et al , ; Quansah et al , ). Moreover, pathogenic mutations in the mpc1 gene were found in rare but severe metabolic syndromes, further enhancing the clinical relevance of this transporter (Bricker et al , ).…”